Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company developing software-based treatments for cardiometabolic diseases, including type 2 diabetes, that came to market through a business combination with Mountain Crest Acquisition Corp. II, a blank-check company sponsored by Mountain Crest Capital LLC. The April 2021 8-K filing reflects a key milestone in the company's SPAC transaction timeline as it pursued a public listing in the healthcare and digital therapeutics sector. Mountain Crest Acquisition Corp. II completed its IPO in 2021, targeting technology-enabled healthcare opportunities before announcing the Better Therapeutics combination. For full filing history, sponsor backgrounds, and deal-level data on BTTX and the broader SPAC universe, sign up for SpacDesk.